Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$23.72
-0.04-0.17%
al cierre: -
$23.75
0.030.13%
After hour: 5:56 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Klaviyo Inc ha un obiettivo di prezzo di consenso pari a $42.92, stabilito in base alle ultime valutazioni degli analisti di 26. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Baird y Stephens & Co. il octubre 1, 2025, septiembre 26, 2025 y septiembre 26, 2025. Con un obiettivo di prezzo medio di $40.67 tra le Wells Fargo, Baird y Stephens & Co., c'è un implicito 71.23% upside per Klaviyo Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Baird
Stephens & Co.
Needham
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Klaviyo
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/01/2025 | 68.42% | Wells Fargo | → $40 | Initiates | → Overweight | |||
09/26/2025 | 64.21% | Baird | $44 → $39 | Maintains | Outperform | |||
09/26/2025 | 81.05% | Stephens & Co. | $45 → $43 | Maintains | Overweight | |||
09/26/2025 | 89.47% | Needham | $45 → $45 | Reiterates | Buy → Buy | |||
09/26/2025 | 110.53% | Piper Sandler | $55 → $50 | Reiterates | Overweight → Overweight | |||
09/19/2025 | 110.53% | Morgan Stanley | $40 → $50 | Upgrade | Equal-Weight → Overweight | |||
08/07/2025 | 110.53% | Citigroup | $40 → $50 | Upgrade | Neutral → Buy | |||
08/06/2025 | 93.68% | TD Cowen | $45 → $46 | Maintains | Buy | |||
08/06/2025 | 131.58% | Piper Sandler | $40 → $55 | Maintains | Overweight | |||
08/06/2025 | 93.68% | Benchmark | $44 → $46 | Maintains | Buy | |||
08/06/2025 | 55.79% | Macquarie | $37 → $37 | Maintains | Neutral | |||
07/15/2025 | 68.42% | Stifel | $45 → $40 | Maintains | Buy | |||
06/13/2025 | 68.42% | Wells Fargo | $32 → $40 | Upgrade | Equal-Weight → Overweight | |||
06/03/2025 | 102.11% | Cantor Fitzgerald | → $48 | Assumes | → Overweight | |||
05/07/2025 | 85.26% | Goldman Sachs | $51 → $44 | Maintains | Buy | |||
05/07/2025 | 85.26% | Benchmark | $43 → $44 | Maintains | Buy | |||
05/07/2025 | 60% | Barclays | $35 → $38 | Maintains | Overweight | |||
05/07/2025 | 89.47% | Needham | $56 → $45 | Maintains | Buy | |||
05/07/2025 | 68.42% | Piper Sandler | $35 → $40 | Maintains | Overweight | |||
05/05/2025 | 34.74% | Wells Fargo | $26 → $32 | Maintains | Equal-Weight | |||
04/24/2025 | 30.53% | Scotiabank | $45 → $31 | Maintains | Sector Perform | |||
04/23/2025 | 47.37% | Piper Sandler | $53 → $35 | Maintains | Overweight | |||
04/23/2025 | 55.79% | Baird | $54 → $37 | Maintains | Outperform | |||
04/22/2025 | 9.47% | Wells Fargo | $45 → $26 | Maintains | Equal-Weight | |||
04/21/2025 | 47.37% | Barclays | $51 → $35 | Maintains | Overweight | |||
04/16/2025 | 43.16% | Morgan Stanley | $50 → $34 | Maintains | Equal-Weight | |||
04/16/2025 | 68.42% | Truist Securities | $55 → $40 | Maintains | Buy | |||
04/15/2025 | 68.42% | Mizuho | $52 → $40 | Maintains | Outperform | |||
03/21/2025 | 81.05% | Stephens & Co. | → $43 | Initiates | → Overweight | |||
03/19/2025 | 81.05% | Stephens & Co. | → $43 | Initiates | → Overweight | |||
02/21/2025 | 135.79% | Needham | $56 → $56 | Reiterates | Buy → Buy | |||
02/21/2025 | 123.16% | Piper Sandler | $53 → $53 | Reiterates | Overweight → Overweight | |||
02/20/2025 | 127.37% | Stifel | $45 → $54 | Maintains | Buy | |||
02/20/2025 | 114.74% | Barclays | $47 → $51 | Maintains | Overweight | |||
02/20/2025 | 114.74% | Goldman Sachs | $45 → $51 | Maintains | Buy | |||
02/20/2025 | 118.95% | Mizuho | $42 → $52 | Maintains | Outperform | |||
02/20/2025 | 110.53% | Canaccord Genuity | $40 → $50 | Maintains | Buy | |||
02/20/2025 | 110.53% | Morgan Stanley | $47 → $50 | Maintains | Equal-Weight | |||
02/20/2025 | 127.37% | Cantor Fitzgerald | $47 → $54 | Maintains | Overweight | |||
02/20/2025 | 127.37% | Baird | $52 → $54 | Maintains | Outperform | |||
02/20/2025 | 127.37% | Benchmark | $51 → $54 | Maintains | Buy | |||
02/20/2025 | 89.47% | Wells Fargo | $48 → $45 | Maintains | Equal-Weight | |||
02/20/2025 | 123.16% | Piper Sandler | $50 → $53 | Maintains | Overweight | |||
02/20/2025 | 135.79% | Needham | $46 → $56 | Maintains | Buy | |||
02/19/2025 | 114.74% | Benchmark | $40 → $51 | Maintains | Buy | |||
02/12/2025 | 102.11% | Wells Fargo | $41 → $48 | Maintains | Equal-Weight | |||
02/11/2025 | 102.11% | Citigroup | $39 → $48 | Maintains | Neutral | |||
01/29/2025 | 89.47% | Scotiabank | $35 → $45 | Maintains | Sector Perform | |||
01/13/2025 | 97.89% | Morgan Stanley | $38 → $47 | Maintains | Equal-Weight | |||
01/07/2025 | 72.63% | Wells Fargo | $37 → $41 | Maintains | Equal-Weight | |||
01/06/2025 | 110.53% | Piper Sandler | $45 → $50 | Maintains | Overweight | |||
12/23/2024 | 152.63% | Loop Capital | $45 → $60 | Maintains | Buy | |||
12/13/2024 | 89.47% | Keybanc | $42 → $45 | Maintains | Overweight | |||
12/06/2024 | 97.89% | Barclays | $43 → $47 | Maintains | Overweight | |||
11/08/2024 | 51.58% | Macquarie | $36 → $36 | Maintains | Neutral | |||
11/07/2024 | 81.05% | Barclays | $41 → $43 | Maintains | Overweight | |||
11/07/2024 | 76.84% | Mizuho | $37 → $42 | Maintains | Outperform | |||
11/07/2024 | 93.68% | Needham | $40 → $46 | Maintains | Buy | |||
11/07/2024 | 68.42% | Canaccord Genuity | $32 → $40 | Maintains | Buy | |||
11/07/2024 | 89.47% | Baird | $42 → $45 | Maintains | Outperform | |||
11/07/2024 | 97.89% | Cantor Fitzgerald | $33 → $47 | Maintains | Overweight | |||
11/07/2024 | 68.42% | Benchmark | $42 → $40 | Maintains | Buy | |||
10/31/2024 | 51.58% | Macquarie | — | → $36 | Initiates | → Neutral | ||
10/24/2024 | 76.84% | Benchmark | $42 → $42 | Reiterates | Buy → Buy | |||
10/22/2024 | 89.47% | Stifel | → $45 | Initiates | → Buy | |||
10/18/2024 | 89.47% | Piper Sandler | $34 → $45 | Maintains | Overweight | |||
10/16/2024 | 55.79% | Wells Fargo | → $37 | Initiates | → Equal-Weight | |||
10/11/2024 | 72.63% | Barclays | $32 → $41 | Maintains | Overweight | |||
10/10/2024 | 76.84% | Baird | $35 → $42 | Maintains | Outperform | |||
09/30/2024 | 76.84% | Benchmark | → $42 | Initiates | → Buy | |||
09/04/2024 | 68.42% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
08/08/2024 | 55.79% | Mizuho | $35 → $37 | Maintains | Outperform | |||
08/08/2024 | 34.74% | Barclays | $29 → $32 | Maintains | Overweight | |||
08/08/2024 | 38.95% | Keybanc | → $33 | Upgrade | Sector Weight → Overweight | |||
08/08/2024 | 38.95% | Cantor Fitzgerald | $31 → $33 | Maintains | Overweight | |||
08/08/2024 | 43.16% | Piper Sandler | $30 → $34 | Maintains | Overweight | |||
07/12/2024 | 26.32% | Piper Sandler | $38 → $30 | Maintains | Overweight | |||
06/12/2024 | 22.11% | Barclays | $25 → $29 | Upgrade | Equal-Weight → Overweight | |||
05/17/2024 | 68.42% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
05/09/2024 | 30.53% | Cantor Fitzgerald | $31 → $31 | Reiterates | Overweight → Overweight | |||
05/09/2024 | 68.42% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
05/09/2024 | 34.74% | Canaccord Genuity | $37 → $32 | Maintains | Buy | |||
05/09/2024 | 5.26% | Barclays | $32 → $25 | Maintains | Equal-Weight | |||
05/09/2024 | 47.37% | Mizuho | $40 → $35 | Maintains | Buy | |||
05/09/2024 | 47.37% | Baird | $40 → $35 | Maintains | Outperform | |||
04/17/2024 | 34.74% | Morgan Stanley | $37 → $32 | Maintains | Equal-Weight | |||
04/16/2024 | 30.53% | Cantor Fitzgerald | → $31 | Initiates | → Overweight | |||
04/02/2024 | 26.32% | Scotiabank | → $30 | Initiates | → Sector Perform | |||
03/21/2024 | — | Keybanc | — | Initiates | → Sector Weight | |||
03/20/2024 | 47.37% | FBN Securities | → $35 | Initiates | → Outperform | |||
03/01/2024 | 68.42% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
02/28/2024 | 68.42% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
02/28/2024 | 55.79% | Morgan Stanley | $38 → $37 | Maintains | Equal-Weight | |||
02/28/2024 | 60% | Piper Sandler | → $38 | Reiterates | Overweight → Overweight | |||
02/05/2024 | 51.58% | Goldman Sachs | → $36 | Upgrade | Neutral → Buy | |||
01/24/2024 | 60% | Piper Sandler | → $38 | Reiterates | Overweight → Overweight | |||
01/12/2024 | 34.74% | Barclays | $37 → $32 | Maintains | Equal-Weight | |||
12/19/2023 | 68.42% | Needham | $40 → $40 | Reiterates | Buy → Buy | |||
12/08/2023 | 68.42% | Loop Capital | → $40 | Initiates | → Buy | |||
11/08/2023 | 60% | Piper Sandler | → $38 | Reiterates | Overweight → Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Klaviyo (KVYO)?
El último precio objetivo de Klaviyo (NYSE:KVYO) fue comunicado por Wells Fargo el octubre 1, 2025. La firma de analistas fijó un precio objetivo para $40.00 que espera KVYO a rise dentro de 12 meses (un posible 68.42% upside). 65 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Klaviyo (KVYO)?
La última calificación de analistas para Klaviyo (NYSE:KVYO) fue proporcionada por Wells Fargo, y Klaviyo iniciado su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Klaviyo (KVYO)?
La última revisión al alza de Klaviyo Inc se produjo en septiembre 19, 2025, cuando Morgan Stanley elevó su precio objetivo a $50. Morgan Stanley anteriormente tenía an equal-weight para Klaviyo Inc.
¿Cuándo fue la última revisión a la baja de Klaviyo (KVYO)?
No hay una última revisión a la baja para Klaviyo.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Klaviyo (KVYO)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Klaviyo, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Klaviyo se registró el octubre 1, 2025, por lo que la próxima calificación estará disponible en torno al octubre 1, 2026.
¿Es correcta la calificación de los analistas sobre Klaviyo (KVYO)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Klaviyo (KVYO) fue un iniciado con un precio objetivo de $0.00 a $40.00. El precio actual al que cotiza Klaviyo (KVYO) es de $23.75, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.